ID: ALA853519
Type: Functional
Description: Efficacy against human recombinant GABA-Aalpha3 plus beta-3-gamma-2 receptor expressed in L(tk-) cells assessed as modulation of chloride ion by whole cell patch clamp method relative to chlorodiazepoxide
Format: BAO_0000219
Organism: Homo sapiens
Target: GABA-A receptor; alpha-3/beta-3/gamma-2(ALA2094120)
Document: ALA1138896
Efficacy against human recombinant GABA-Aalpha3 plus beta-3-gamma-2 receptor expressed in L(tk-) cells assessed as modulation of chloride ion by whole cell patch clamp method relative to chlorodiazepoxide: 1
Bioactivity
Activity Types for Assay ALA853519
Efficacy
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
401.41 | 3.30 | 3.30 |
419.40 | 3.44 | 3.44 |
419.40 | 3.44 | 3.44 |
435.85 | 3.96 | 3.96 |
435.85 | 3.96 | 3.96 |
426.42 | 3.18 | 3.18 |
437.39 | 3.58 | 3.58 |
419.40 | 3.44 | 3.44 |
437.39 | 3.58 | 3.58 |
437.39 | 3.58 | 3.58 |
419.40 | 3.44 | 3.44 |
437.39 | 3.58 | 3.58 |
437.39 | 3.58 | 3.58 |
437.39 | 3.58 | 3.58 |
407.43 | 3.37 | 3.37 |
455.38 | 3.72 | 3.72 |
365.37 | 2.52 | 2.52 |
469.40 | 4.32 | 4.32 |
407.43 | 3.37 | 3.37 |
391.37 | 2.90 | 2.90 |
455.38 | 3.72 | 3.72 |
431.43 | 2.80 | 2.80 |
416.42 | 2.89 | 2.89 |
402.39 | 2.70 | 2.70 |
435.85 | 3.96 | 3.96 |
402.39 | 2.70 | 2.70 |
419.40 | 3.44 | 3.44 |
402.39 | 2.70 | 2.70 |
402.39 | 2.70 | 2.70 |
404.39 | 1.31 | 1.31 |
391.37 | 2.90 | 2.90 |
391.37 | 2.90 | 2.90 |
389.44 | 3.23 | 3.23 |